1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow BI 3000202: new trials by email Literature Review of BI 3000202 trials Research Report on BI 3000202
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE) BI 3000202, Placebo - Systemic Lupus Erythematosus | Phase 2 | Recruiting | Boehringer Ingelheim | 405 | 2026-04-20 | 2026-10-28 |
Lupus Erythematosus, Systemic (1)
Argentina (1) · Australia (1) · Brazil (1) · Bulgaria (1) · China (1) · Colombia (1) · Croatia (1) · Germany (1) · Hungary (1) · India (1) · Japan (1) · Mexico (1) · Netherlands (1) · Poland (1) · Romania (1)
2025 (1)